Different guidelines call for all adults to engage in at least 150 minutes/week of moderate to vigorous physical activity. It is well-known that regular physical activity reduces the risk of systemic inflammation, which is a major contributor to lun...
World Health Organization (WHO) conducted a large, open-label, randomised-controlled trial involving hospital inpatients to evaluate the effects of remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a on mortality caused by Covid-19. Th...
China Has Begun the Monoclonal Neutralising Antibody Phase 1 Clinical Trial against COVID-19 China has begun the recombinant fully human monoclonal neutralising antibody (JS016) phase 1 clinical trial against COVID-19 in Shanghai on 7 June 2020 afte...
In order to combat the current outbreak of pneumonia caused by a novel coronavirus (nCoV) reported in Wuhan, China, Chinese scientists select 30 medications including traditional Chinese medicines as candidates against nCoV 1 . In particular, an ant...
The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing and has spread to other regions in China and overseas. It has been reported that the estimated basic reproductive number (Ro) of COVID-19 repo...
The outbreak of atypical pneumonia caused by novel coronavirus (COVID-19) in Wuhan, China is still ongoing. As of 19-March, 2020, there have been more than 80,928 confirmed cases of infections and 3,245 deaths in mainland China. Besides, there are 7...
